Myriad Women's Health

30 articles about Myriad Women's Health

• Myriad Announces Closing of Counsyl Acquisition

  7/31/2018

  Myriad Genetics, Inc. (NASDAQ: MYGN), a global leader in personalized medicine, announced today that it has completed the acquisition of Counsyl, Inc. a leader in reproductive genetic testing based in South San Francisco, Calif.  

• Counsyl to Offer Insight Into Streamlining Genetic Screening Into OBGYN Practice at the 2018 ACOG Annual Clinical and Scientific Meeting

  4/18/2018

  Counsyl will share insights into how OBGYNs can seamlessly integrate genetic screening into their practices at the 2018 American College of Obstetricians and Gynecologists (ACOG) Annual Clinical and Scientific Meeting, held from April 27 to April 30 in Austin, Texas.

• Counsyl Highlights Importance of Patient Access to Genetic Testing at the 2018 ACMG Annual Clinical Genetics Meeting

  4/4/2018

  Counsyl leaders will offer TED-style talk, two platform presentations and two posters at the conference, and will host a CME satellite symposium focused on improving workforce efficiency in genetics

• Counsyl Secures Approval From New York State Department of Health for Prelude Prenatal Screen

  1/16/2018

  Counsyl can now work more closely with existing and new providers to offer patients early insights about their baby’s development.

• Counsyl Appoints Ann Rhoads to Board of Directors

  1/4/2018

  Counsyl today announced the appointment of Ann Rhoads, former executive vice president and chief financial officer at pharmaceutical company,

• Counsyl Appoints Pamela Sedmak to Board of Directors

  12/14/2017

  Counsyl today announced the appointment of Pamela Sedmak, former president and chief executive officer of Aetna Medicaid/Dual Eligibles and current senior advisor at McKinsey & Company, to the company’s board of directors.

• Counsyl Appoints Noah Nasser as Chief Commercial Officer

  12/4/2017

  Since joining Counsyl in October 2016, Nasser has played a pivotal role in driving the sales strategy for Counsyl, bringing the company’s suite of genetic screening products and services to women’s health clinics nationwide.

• 

  Counsyl Celebrates Anniversary With $80M Funding Round

  11/7/2017

  The increased funding showcases investor confidence in Counsyl’s leading genetic screening products and business model.

• Counsyl Unveils Updated Names For Its Portfolio Of Genetic Testing Products And Services

  7/19/2017

• Counsyl And Angsana Bring Expanded Carrier Screening To Clinicians And Patients In Hong Kong

  7/10/2017

• Counsyl Release: New Study Finds Non-Invasive Prenatal Screening Using Whole-Genome Sequencing Detects More Chromosomal Abnormalities At Low Fetal Fraction, Minimizes Unnecessary Invasive Procedures

  5/11/2017

• SYNLAB And Counsyl Enter Into Agreement To Offer Genetic Screening For Serious Inherited Health Conditions In Europe And Latin America

  4/26/2017

• Counsyl Supports New Guidance From American College of Obstetricians and Gynecologist On Expanded Carrier Screening For Prenatal Genetic Testing

  3/9/2017

• Counsyl Strengthens Focus On Preventive Genetic Testing For Women’s Health

  1/9/2017

• Bay Area Genetic Testing Firm Counsyl Lays Off Oncology Sales Team

  1/9/2017

• Counsyl To Present 11 Abstracts At National Society Of Genetic Counselors (NSGC) Annual Education Conference

  9/29/2016

• Counsyl Appoints Chief Financial Officer And General Counsel

  7/21/2016

• Counsyl Announces Major Oncology Expansion To Advance Genetic Screening For Cancer Risk

  5/25/2016

• Counsyl Appoints Distinguished Medical And Scientific Industry Veterans To Board

  5/17/2016

• Counsyl To Present At The 2016 American College of Obstetricians and Gynecologist Annual Clinical And Scientific Meeting

  5/9/2016